ABBV Stock: Unusual Call Activity Targets $270 Strike as AbbVie Trades Near 52-Week High

By TrendSpider Editor

ABBV market update based on latest unusual_options data.

ABBV Stock: Unusual Call Activity Targets $270 Strike as AbbVie Trades Near 52-Week High

AbbVie Inc. is drawing notable options attention today, with four unusual call contracts totaling $960,000 in combined premium as the stock trades at $235.00, up 0.54% in the current session. The heaviest single contract is a $329,000 premium play on a $270 call expiring June 18, 2026, signaling that some traders are positioning for a meaningful move higher over the next several months. With ABBV trading near the upper end of its 52-week range of $164.39 to $244.81, the options flow suggests conviction among at least some market participants that the stock has room to run.

Key Drivers of the ABBV Stock Move

• Main Catalyst: Four unusual call contracts hit the tape today across multiple strikes and expirations, generating $960,000 in total premium. Activity was concentrated at the $270 strike, where two separate contracts accounted for $723,800 of the total premium, with sizes of 1,000 and 1,200 contracts expiring June 18, 2026.
• Bull Case: The $270 strike calls, representing the bulk of today's unusual flow, imply a roughly 14.9% move above the current price of $235.00. The fact that two distinct orders hit the same strike and expiry on the same session suggests coordinated or high-conviction directional positioning, and ABBV has already demonstrated the range capacity given its 52-week high of $244.81.
• Bear Case: All four contracts are calls, and three of the four are out of the money, meaning buyers lose their entire premium if ABBV fails to reach the respective strikes by expiration. The $240 call expiring March 20, 2026 carries an open interest ratio of just 6%, suggesting limited existing positioning at that level, and the near-term expiry leaves little time for the trade to work.

The forward setup for ABBV is shaped by the interplay between its strong proximity to 52-week highs and the aggressive out-of-the-money call positioning seen today. The $270 June calls in particular indicate that some traders are looking well beyond the current price ceiling established by the 52-week high of $244.81. For those contracts to pay off, AbbVie would need to break meaningfully into new high territory over the next approximately three and a half months. Investors should monitor whether volume continues to build at the $270 strike in coming sessions, as repeated accumulation at a single strike often precedes either a fundamental catalyst or a broader sector rotation into large-cap biopharma names.

ABBV Unusual Options Activity

• Call | Strike: $235 | Expiry: April 10, 2026 | Volume: 50 | Open Interest: 357% (ITM)
• Call | Strike: $240 | Expiry: March 20, 2026 | Volume: 644 | Open Interest: 6% (OTM)
• Call | Strike: $270 | Expiry: June 18, 2026 | Volume: 1,000 | Open Interest: 32% (OTM)
• Call | Strike: $270 | Expiry: June 18, 2026 | Volume: 1,200 | Open Interest: 39% (OTM)

All four unusual contracts are calls, with zero puts in today's unusual flow. The total unusual contract count stands at 4, and the combined premium across all contracts is $960,000. The $235 strike call expiring April 10, 2026 is the only in-the-money contract in the group, carrying a notably elevated open interest reading of 357%, which suggests significant existing positioning relative to average volume at that strike. The two $270 strike contracts share the same expiration and together represent the dominant theme in today's flow.

ABBV Seasonality

March and the early second quarter have historically been an active period for large-cap pharmaceutical names as pipeline updates, conference presentations, and first-quarter earnings guidance come into focus. For ABBV specifically, options activity building in late winter ahead of a mid-June expiry aligns with a window that often captures both spring catalyst events and any early readouts from ongoing clinical programs.

ABBV Relative Performance

ABBV is up 0.54% today at $235.00, trading approximately 43% above its 52-week low of $164.39 and within roughly 4% of its 52-week high of $244.81. This positioning near the top of its annual range reflects relative strength versus the broader market, and the concentration of today's unusual options flow at strikes above the current 52-week high suggests traders are not treating the $244.81 level as a firm ceiling going into the summer months.